Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS031506-03
Application #
2269435
Study Section
Neurological Disorders Program Project Review B Committee (NSPB)
Program Officer
Kerza-Kwiatecki, a P
Project Start
1993-12-15
Project End
1997-11-30
Budget Start
1995-12-01
Budget End
1997-11-30
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905

  Publications

Noseworthy, J H; O'Brien, P C; Weinshenker, B G et al. (2000) IV immunoglobulin does not reverse established weakness in MS. Neurology 55:1135-43
Noseworthy, J H; Lucchinetti, C; Rodriguez, M et al. (2000) Multiple sclerosis. N Engl J Med 343:938-52
Lucchinetti, C F; Noseworthy, J H; Rodriguez, M (1997) Promotion of endogenous remyelination in multiple sclerosis. Mult Scler 3:71-5
Miller, D J; Asakura, K; Rodriguez, M (1996) Central nervous system remyelination clinical application of basic neuroscience principles. Brain Pathol 6:331-44
Miller, D J; Asakura, K; Rodriguez, M (1995) Experimental strategies to promote central nervous system remyelination in multiple sclerosis: insights gained from the Theiler's virus model system. J Neurosci Res 41:291-6
Noseworthy, J H; O'Brien, P C; van Engelen, B G et al. (1994) Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial. J Neurol Neurosurg Psychiatry 57 Suppl:11-4